Desh Rakshak Aushdhalaya Limited, a manufacturer of Ayurvedic and herbal products established in 1901, has filed its annual regulatory disclosure with BSE Limited. The company submitted its yearly disclosure under SEBI's substantial acquisition regulations for the financial year ended March 31, 2026.

Regulatory Compliance Filing

The disclosure was submitted on April 6, 2026, by Company Secretary and Compliance Officer Sohini Bansal to BSE Limited's Corporate Compliance Department. The filing pertains to sub-regulation (4) and (5) of Regulation 31 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Promoter Declaration

Tosh Kumar Jain, promoter of the company, submitted a declaration on behalf of himself and the promoter group. The declaration confirms compliance with SEBI regulations regarding share encumbrance for the financial year ended March 31, 2026.

The promoter declared that as of March 31, 2026, the promoters and promoter group, together with persons acting in concert, have not made any encumbrance directly or indirectly over the shares held by them during the financial year.

Company Background

Desh Rakshak Aushdhalaya Limited operates from Bhagwant Kuti Kankhal in Haridwar, Uttarakhand. The company specializes in manufacturing Ayurvedic and herbal products and has been in operation since 1901. The company is incorporated under CIN L33119UR1981PLC006092.

Corporate Governance

The filing demonstrates the company's commitment to regulatory compliance and transparency. Company Secretary Sohini Bansal, holding ICSI Membership No. 64620, ensured timely submission of the required disclosures to maintain good corporate governance standards.

The declaration was also copied to the company's Audit Committee, ensuring internal governance protocols are followed alongside regulatory requirements.

Desh Rakshak Aushdhalaya Limited has filed a statement with BSE Limited confirming no deviation in the use of proceeds from its preferential allotment for the quarter ended December 31, 2025. The ayurvedic and herbal product manufacturer submitted the compliance report on February 13, 2026, pursuant to Regulation 32 of SEBI Listing Regulations.

Preferential Issue Details

The company raised funds through the allotment of equity shares on preferential basis, with specific terms outlined in the regulatory filing.

Fund Utilization Status

The company allocated the raised funds across two primary objectives, both of which have been utilized according to the original plan without any deviation.

Regulatory Compliance

The statement was prepared in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The Audit Committee reviewed and approved the fund utilization statement at its meeting held on February 13, 2026.

The company confirmed that there is no deviation in the objects or purposes for which the funds were raised, no deviation in the amount of funds actually utilized as against what was originally disclosed, and no change in terms of the contract referred to in the fund raising document.

Company Background

Desh Rakshak Aushdhalaya Limited, established in 1901, is a manufacturer of ayurvedic and herbal products based in Haridwar, Uttarakhand. The company is listed on BSE with scrip code 531521 and operates under CIN L33119UR1981PLC006092. Managing Director Tosh Kumar Jain signed the regulatory filing confirming the proper utilization of preferential issue proceeds.